Literature DB >> 29659173

Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL.

R Favre1, D Manzoni1, A Traverse-Glehen2,3, A Verney3, L Jallades1,3, E Callet-Bauchu1,3, P Sujobert1,3, G Salles3,4, L Baseggio1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29659173     DOI： 10.1111/ijlh.12824

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  7 in total

1.  "Hairy Cell Leukemia (HCL): 'Real World' Outcome".

Authors:  Archit Joshi; Manikandan Dhanushkodi; Prasanth Ganesan; Venkatraman Radhakrishnan; Krishnarathinam Kannan; Nikita Mehra; Jayachandran Perumal Kalaiyarasi; S Krupashankar; Shirley Sundersingh; T S Ganesan; T G Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-28       Impact factor: 0.900

Review 2.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

Review 3.  Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.

Authors:  Jérôme Paillassa; Elsa Maitre; Xavier Troussard
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

4.  Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.

Authors:  Elsa Maitre; Cécile Tomowiak; Benjamin Lebecque; Fontanet Bijou; Khaled Benabed; Dina Naguib; Pauline Kerneves; Edouard Cornet; Pierre-Julien Viailly; Jeffrey Arsham; Brigitte Sola; Fabrice Jardin; Xavier Troussard
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

Review 5.  Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.

Authors:  Jérôme Paillassa; Firas Safa; Xavier Troussard
Journal:  Ther Adv Hematol       Date:  2022-04-13

Review 6.  CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.

Authors:  Giovanni D'Arena; Vincenzo De Feo; Giuseppe Pietrantuono; Elisa Seneca; Giovanna Mansueto; Oreste Villani; Francesco La Rocca; Fiorella D'Auria; Teodora Statuto; Luciana Valvano; Francesca Arruga; Silvia Deaglio; Dimitar G Efremov; Alessandro Sgambato; Luca Laurenti
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

7.  Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.

Authors:  Elsa Maitre; Edouard Cornet; Véronique Salaün; Pauline Kerneves; Stéphane Chèze; Yohan Repesse; Gandhi Damaj; Xavier Troussard
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.